Topical formulation

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8748467
APP PUB NO 20100137389A1
SERIAL NO

12524421

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The invention relates to composition and related therapeutic methods including at least one antihyperthyroid drug formulated for transdermal administration. Because the formulation is formulated for transdermal administration, the formulation is easier to administer than existing formulations which are administered orally to animals. Issues surrounding transdermal administration versus oral administration have also been resolved allowing the agent to remain stable during storage and retain a high level of efficacy.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ELANCO NEW ZEALANDAUCKLAND 1024

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Al, Alawi Fadil Auckland, NZ 7 2
Chambers, Paul Palmerston North, NZ 30 848
Hill, Kate Palmerston North, NZ 1 1
Nanjan, Karthigeyan Auckland, NZ 6 3

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Dec 10, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00